LX9211

Lexicon CEO touts ‘wonderful morning’ as diabetic pain drug clears phase 2, teeing up hopeful partnership talks
Fierce Biotech
Thu, 06/30/22 - 11:03 am
Lexicon Pharmaceuticals
diabetic neuropathy
diabetes
diabetic pain
clinical trials
LX9211